Brenda Mann - Oct 4, 2021 Form 4 Insider Report for EYEGATE PHARMACEUTICALS INC (KPRX)

Role
VP of Research & Development
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Oct 4, 2021
Transactions value $
-$125
Form type
4
Date filed
10/5/2021, 06:40 PM
Previous filing
Sep 3, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -$125 -62 -0.41% $2.01 15.2K Oct 4, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021.